Want to see IN:NH full AI Analyst Report?
NH Stock Chart & Stats
₹1756.45
₹14.10(1.04%)
At close: 4:00 PM EST
₹1756.45
₹14.10(1.04%)
Day’s Range― - ―
52-Week Range₹1,564.25 - ₹2,200.00
Previous CloseN/A
Volume860.19K
Average Volume (3M)80.08K
Market Cap
₹402.83B
Enterprise Value₹425.21B
Total Cash (Recent Filing)₹18.24B
Total Debt (Recent Filing)₹23.40B
Price to Earnings (P/E)49.8
Beta0.77
Next Earnings
Jul 31, 2026EPS Estimate
12.8Next Dividend Ex-DateN/A
Dividend Yield0.24%
Share Statistics
EPS (TTM)41.53
Shares Outstanding204,360,800
10 Day Avg. Volume19,057
30 Day Avg. Volume80,081
Financial Highlights & Ratios
PEG Ratio19.78
Price to Book (P/B)7.32
Price to Sales (P/S)4.21
P/FCF Ratio55.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)56.52
Revenue Forecast (FY)₹104.64B
Bulls Say, Bears Say
Bulls Say
Accelerating Revenue GrowthSustained double-digit to high-teens revenue acceleration reflects stronger patient volumes and higher case mix in tertiary services; this growth supports scale economics, revenue diversification across inpatient/outpatient/diagnostics, and provides a multi-month runway for margin expansion if utilization holds.
Improved Cash GenerationA meaningful rebound in operating and free cash flow improves liquidity to fund capex, working capital and strategic investments without relying solely on external financing; stronger cash generation over several quarters increases resilience and ability to delever or invest in capacity.
Specialist Network And Service MixA focused multi- and super-specialty hospital network, anchored by cardiac care, creates durable competitive advantages via referral flows, higher-value procedures and institutional relationships; diversified service lines and geographic footprint support steady demand and pricing resilience over months.
Bears Say
Sharp Increase In LeverageA large one-year jump in debt materially increases financial risk: higher interest costs and tighter covenants reduce flexibility to invest or absorb shocks. If operating growth falters, elevated leverage raises refinancing and solvency risks over the coming 2–6 months.
Volatile Free Cash FlowLarge swings in free cash flow signal sensitivity to capex timing and working-capital moves; this volatility complicates capital allocation, debt servicing and sustained reinvestment plans. Repeated swings could force external funding or deferment of strategic projects.
Margin And Profitability VariabilityInter-year margin variability undermines earnings predictability and raises execution risk; with high fixed costs in hospitals, any drop in occupancy or adverse case mix could compress margins quickly, stressing cash flow and making sustained profitability less certain.
Narayana Hrudayalaya Ltd. News
NH FAQ
What was Narayana Hrudayalaya Ltd.’s price range in the past 12 months?
Narayana Hrudayalaya Ltd. lowest stock price was ₹1564.25 and its highest was ₹2200.00 in the past 12 months.
What is Narayana Hrudayalaya Ltd.’s market cap?
Narayana Hrudayalaya Ltd.’s market cap is ₹402.83B.
When is Narayana Hrudayalaya Ltd.’s upcoming earnings report date?
Narayana Hrudayalaya Ltd.’s upcoming earnings report date is Jul 31, 2026 which is in 30 days.
How were Narayana Hrudayalaya Ltd.’s earnings last quarter?
Narayana Hrudayalaya Ltd. released its earnings results on May 22, 2026. The company reported ₹11.2 earnings per share for the quarter, missing the consensus estimate of ₹13.1 by -₹1.9.
Is Narayana Hrudayalaya Ltd. overvalued?
According to Wall Street analysts Narayana Hrudayalaya Ltd.’s price is currently Overvalued.
Does Narayana Hrudayalaya Ltd. pay dividends?
Narayana Hrudayalaya Ltd. pays a Annually dividend of ₹4.496 which represents an annual dividend yield of 0.24%. See more information on Narayana Hrudayalaya Ltd. dividends here
What is Narayana Hrudayalaya Ltd.’s EPS estimate?
Narayana Hrudayalaya Ltd.’s EPS estimate is 12.8.
How many shares outstanding does Narayana Hrudayalaya Ltd. have?
Narayana Hrudayalaya Ltd. has 204,360,800 shares outstanding.
What happened to Narayana Hrudayalaya Ltd.’s price movement after its last earnings report?
Narayana Hrudayalaya Ltd. reported an EPS of ₹11.2 in its last earnings report, missing expectations of ₹13.1. Following the earnings report the stock price went down -3.855%.
Which hedge fund is a major shareholder of Narayana Hrudayalaya Ltd.?
Currently, no hedge funds are holding shares in IN:NH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Narayana Hrudayalaya Ltd.
Narayana Hrudayalaya Limited, established in 2000 and headquartered in Bengaluru, India, operates as a prominent provider of medical and healthcare services. The company oversees and manages a diverse range of healthcare facilities, encompassing hospitals, clinics, health centers, and nursing homes. It delivers specialized care across a comprehensive spectrum of medical disciplines, including cardiology, cardiac surgery, nephrology, urology, neurology, neuro-surgery, endocrinology, orthopedics, internal medicine, obstetrics, gynecology, pediatrics, neonatology, gastroenterology, and oncology. As of June 30, 2022, Narayana Hrudayalaya maintained an extensive network that included 19 owned or operated hospitals, 2 managed hospitals, 4 heart centers, and 18 clinics and information centers throughout India, complemented by an international presence with one hospital in the Cayman Islands. Additionally, the company extends its expertise through healthcare consultancy services, which involve the licensing of its ERP solutions.
Technical Analysis
Apollo Hospitals Enterprise Limited
―
Aster DM Healthcare Ltd.
―
Fortis Healthcare Ltd.
―
Max Healthcare Institute Ltd
―
Global Health Limited
―







